Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea in diabetes
- 1 February 2023
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 15 (681), eabq4126
- https://doi.org/10.1126/scitranslmed.abq4126
Abstract
Sulfonylureas (SUs) are effective and affordable antidiabetic drugs. However, chronic use leads to secondary failure, limiting their utilization. Here, we identify cytochrome b5 reductase 3 (Cyb5r3) down-regulation as a mechanism of secondary SU failure and successfully reverse it. Chronic exposure to SU lowered Cyb5r3 abundance and reduced islet glucose utilization in mice in vivo and in ex vivo murine islets. Cyb5r3 β cell–specific knockout mice phenocopied SU failure. Cyb5r3 engaged in a glucose-dependent interaction that stabilizes glucokinase (Gck) to maintain glucose utilization. Hence, Gck activators can circumvent Cyb5r3-dependent SU failure. A Cyb5r3 activator rescued secondary SU failure in mice in vivo and restored insulin secretion in ex vivo human islets. We conclude that Cyb5r3 is a key factor in the secondary failure to SU and a potential target for its prevention, which might rehabilitate SU use in diabetes.Keywords
This publication has 48 references indexed in Scilit:
- Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell FailureCell, 2012
- Treating diabetes today: a matter of selectivity of sulphonylureasDiabetes, Obesity and Metabolism, 2011
- Tetrahydroindenoindole inhibits the progression of diabetes in miceChemico-Biological Interactions, 2009
- Chronic Antidiabetic Sulfonylureas In Vivo: Reversible Effects on Mouse Pancreatic β-CellsPLoS Medicine, 2008
- BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosisNature, 2003
- ATP-SENSITIVE POTASSIUM CHANNELS: A Model of Heteromultimeric Potassium Channel/Receptor AssembliesAnnual Review of Physiology, 1999
- SULFONYLUREASEndocrinology and Metabolism Clinics of North America, 1997
- Pancreatic β-Cell-specific Targeted Disruption of Glucokinase GeneOnline Journal of Public Health Informatics, 1995
- Abnormal Patterns of Insulin Secretion in Non-Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1988
- Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamideDiabetologia, 1980